Home
SNSE
SNSE News

Latest Sensei Biotherapeutics Inc. (SNSE) News on December 19, 2024

Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference

GlobeNewswire

21 days ago

Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

a month ago

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

GlobeNewswire

2 months ago

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

3 US Penny Stocks To Monitor In October 2024

Simply Wall St.

2 months ago

3 US Penny Stocks To Monitor In October 2024

Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference

GlobeNewswire

3 months ago

Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference

Sensei Biotherapeutics to Present at Upcoming Conferences

GlobeNewswire

3 months ago

Sensei Biotherapeutics to Present at Upcoming Conferences

Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

4 months ago

Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference

GlobeNewswire

7 months ago

Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

GlobeNewswire

7 months ago

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire

7 months ago

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

GlobeNewswire

8 months ago

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference

GlobeNewswire

8 months ago

Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment

GlobeNewswire

8 months ago

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment

Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium

GlobeNewswire

9 months ago

Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium

Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences

GlobeNewswire

9 months ago

Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences

Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

GlobeNewswire

10 months ago

Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

Sensei Biotherapeutics to Present at Upcoming Conferences

GlobeNewswire

10 months ago

Sensei Biotherapeutics to Present at Upcoming Conferences

Rand Capital’s Board of Directors Approves Reduction of Asset Coverage Requirement

Business Wire

a year ago

Rand Capital’s Board of Directors Approves Reduction of Asset Coverage Requirement

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study

Zacks

a year ago

Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study

Profound Medical Announces Non-Brokered Private Placement

GlobeNewswire

a year ago

Profound Medical Announces Non-Brokered Private Placement

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger

Simply Wall St.

a year ago

Natural Grocers by Vitamin Cottage (NYSE:NGVC) Has Some Way To Go To Become A Multi-Bagger

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

GlobeNewswire

a year ago

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

GlobeNewswire

a year ago

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

GlobeNewswire

a year ago

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC

GlobeNewswire

a year ago

OSS Joins Two Key U.S. DoD Consortiums, SCEC and SOSSEC

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

GlobeNewswire

a year ago

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Business Wire

a year ago

Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi

Business Wire

a year ago

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

GlobeNewswire

a year ago

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

City Office REIT Announces Dividends for Fourth Quarter 2023

PR Newswire

a year ago

City Office REIT Announces Dividends for Fourth Quarter 2023

IPA Announces Closing of $1.265 Million Public Offering of Common Shares

Business Wire

a year ago

IPA Announces Closing of $1.265 Million Public Offering of Common Shares

AMAZFIT LAUNCHES NEW SPECIAL EDITIONS OF AMAZFIT BALANCE, AND PARTNERS WITH NON-PROFIT ONE TREE PLANTED TO SUPPORT REFORESTATION PROJECTS IN EUROPE

PR Newswire

a year ago

AMAZFIT LAUNCHES NEW SPECIAL EDITIONS OF AMAZFIT BALANCE, AND PARTNERS WITH NON-PROFIT ONE TREE PLANTED TO SUPPORT REFORESTATION PROJECTS IN EUROPE

Loop Media Schedules Full Year 2023 and Fiscal Fourth Quarter Conference Call for December 12, 2023 at 5:00 p.m. ET

Business Wire

a year ago

Loop Media Schedules Full Year 2023 and Fiscal Fourth Quarter Conference Call for December 12, 2023 at 5:00 p.m. ET

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

TRX Gold Reports Year-End 2023 Results

GlobeNewswire

a year ago

TRX Gold Reports Year-End 2023 Results

LCNB Corp. Agrees to Acquire Eagle Financial Bancorp, Inc.

Business Wire

a year ago

LCNB Corp. Agrees to Acquire Eagle Financial Bancorp, Inc.

Quad Releases 2023 ESG Update

Business Wire

a year ago

Quad Releases 2023 ESG Update

BeautyHealth Announces Leadership Transition

Business Wire

a year ago

BeautyHealth Announces Leadership Transition

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript

Weak Financial Prospects Seem To Be Dragging Down Vox Royalty Corp. (TSE:VOXR) Stock

Simply Wall St.

a year ago

Weak Financial Prospects Seem To Be Dragging Down Vox Royalty Corp. (TSE:VOXR) Stock

Business Wire

a year ago

The ONE Group Reports Third Quarter 2023 Financial Results

Sensei Biotherapeutics Inc (SNSE) Reports Q3 2023 Financial Results

GuruFocus.com

a year ago

Sensei Biotherapeutics Inc (SNSE) Reports Q3 2023 Financial Results

Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

GlobeNewswire

a year ago

Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Share on Social Networks: